DA
AXSM icon

Duality Advisers’s Axsome Therapeutics AXSM Stock Holding History

Duality Advisers’s Portfolio AXSM Stock Details AXSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-36,793
Closed -$1.21M – 499
2021
Q3 		$1.21M Buy
+36,793
New +$1.43M 0.09% 318
2021
Q2 		– Sell
-16,794
Closed -$951K – 534
2021
Q1 		$951K Buy
16,794
+10,289
+158% +$724K 0.08% 356
2020
Q4 		$530K Sell
6,505
-9,695
-60% -$725K 0.04% 437
2020
Q3 		$1.15M Buy
+16,200
New +$1.26M 0.07% 341

Other funds holding AXSM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
ACM
Alethea Capital Management Mercer Island, Washington $195M AUM 51.17% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
IAM
Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return